Application 207595
- Type
- ANDA
- Sponsor
- MYLAN LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NALBUPHINE HYDROCHLORIDE | NALBUPHINE HYDROCHLORIDE | INJECTABLE;INJECTION | 10MG/ML | No | No |
| 002 | NALBUPHINE HYDROCHLORIDE | NALBUPHINE HYDROCHLORIDE | INJECTABLE;INJECTION | 20MG/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207595-001 | NALBUPHINE HYDROCHLORIDE | NALBUPHINE HYDROCHLORIDE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 2019-01-11 | ||
| A207595-002 | NALBUPHINE HYDROCHLORIDE | NALBUPHINE HYDROCHLORIDE | 20MG/ML (20MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 2019-01-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 2019-01-11 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML (20MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 2019-01-11 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 2019-01-11 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML (20MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 2019-01-11 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 2019-01-11 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML (20MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 2019-01-11 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 2019-01-11 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML (20MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 2019-01-11 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 2019-01-11 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML (20MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 2019-01-11 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | 2019-01-11 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML | INJECTABLE / INJECTION | 2019-01-11 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | 2019-01-11 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML | INJECTABLE / INJECTION | 2019-01-11 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | 2019-01-11 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML | INJECTABLE / INJECTION | 2019-01-11 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | 2019-01-11 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML | INJECTABLE / INJECTION | 2019-01-11 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML | INJECTABLE / INJECTION | 2019-01-11 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A207595-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | 2019-01-11 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A207595-002 | NALBUPHINE HYDROCHLORIDE | 20MG/ML | INJECTABLE / INJECTION | AP | 2019-01-11 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A207595-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A207595-002 | AP | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A207595-001 | AP | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A207595-002 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A207595-001 | AP | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A207595-002 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A207595-001 | AP | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A207595-002 | AP | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | Hospira, Inc. | a99fe500-f52b-483c-807c-178f1a78a02b | 2026-07-16 | Boxed warning, Warnings, Adverse reactions | Nalbuphine Hydrochloride NALBUPHINE HYDROCHLORIDE |
| Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | Henry Schein, Inc. | dd621bfa-ce48-4c27-b247-a6d885f70b72 | 2026-04-27 | Boxed warning, Warnings, Adverse reactions | Nalbuphine Hydrochloride NALBUPHINE HYDROCHLORIDE |
| Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | Henry Schein, Inc. | 4ef2c0dc-3ab4-4bb1-aff0-523e3c23ad2d | 2026-04-24 | Boxed warning, Warnings, Adverse reactions | Nalbuphine Hydrochloride NALBUPHINE HYDROCHLORIDE |
| Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | Hospira, Inc. | 6025e8d4-5083-4c3a-58a0-050e7b0b6150 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | Nalbuphine Hydrochloride NALBUPHINE HYDROCHLORIDE |
| Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | ProPharma Distribution | 38569b5f-fb37-135e-e063-6294a90a54df | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | Nalbuphine Hydrochloride NALBUPHINE HYDROCHLORIDE |
| Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | Henry Schein, Inc. | 596826ff-e471-4d4f-9a73-2a34e2af2dd6 | 2025-05-21 | Boxed warning, Warnings, Adverse reactions | Nalbuphine Hydrochloride NALBUPHINE HYDROCHLORIDE |
| Nalbuphine hydrochloride | NALBUPHINE HYDROCHLORIDE | Somerset Therapeutics, LLC | a3221c05-5822-4ab8-b589-0e3939b91a68 | 2025-03-26 | Boxed warning, Adverse reactions | Nalbuphine hydrochloride NALBUPHINE HYDROCHLORIDE |
| Nalbuphine hydrochloride | NALBUPHINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 292b0d0e-f222-d384-e063-6394a90acd44 | 2024-12-13 | Boxed warning, Adverse reactions | Nalbuphine hydrochloride NALBUPHINE HYDROCHLORIDE |
| Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 28f274a4-62c4-4e54-e063-6394a90a2200 | 2024-12-10 | Boxed warning, Warnings, Adverse reactions | Nalbuphine Hydrochloride NALBUPHINE HYDROCHLORIDE |
| Nalbuphine hydrochloride | NALBUPHINE HYDROCHLORIDE | Somerset Therapeutics, LLC | d82dafac-cce7-445a-8127-2a10b6d947ca | 2024-09-26 | Boxed warning, Adverse reactions | Nalbuphine hydrochloride NALBUPHINE HYDROCHLORIDE |
| Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 6bde2184-5643-3ec6-e053-2991aa0a115f | 2023-05-23 | Boxed warning, Warnings, Adverse reactions | Nalbuphine Hydrochloride NALBUPHINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.